Sichuan Dowell Science and Technology Inc.
300535.SZ · SHZ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.85 | -0.04 | 7.11 | 1.73 |
| FCF Yield | -4.04% | -1.99% | -1.04% | -3.36% |
| EV / EBITDA | 52.49 | 35.59 | 50.13 | 15.27 |
| Quality | ||||
| ROIC | -2.46% | 0.30% | -1.11% | 5.89% |
| Gross Margin | 35.56% | 29.80% | 28.26% | 36.89% |
| Cash Conversion Ratio | -1.60 | 2.10 | -2.66 | 0.82 |
| Growth | ||||
| Revenue 3-Year CAGR | 13.85% | 4.78% | 2.81% | 16.69% |
| Free Cash Flow Growth | -43.46% | -176.06% | 74.05% | 2.27% |
| Safety | ||||
| Net Debt / EBITDA | 7.10 | 3.39 | 5.66 | 0.90 |
| Interest Coverage | -2.77 | 1.34 | -1.89 | 14.85 |
| Efficiency | ||||
| Inventory Turnover | 2.79 | 2.63 | 1.75 | 1.74 |
| Cash Conversion Cycle | 261.09 | 236.58 | 335.57 | 302.69 |